Cloning and expression of a single human immunoglobulin heavy-chain variable domain with vascular endothelial growth factor binding activity.
- Author:
Heng LIU
1
;
Siguo LIU
;
Yi WU
;
M ZILI
;
Yu LIU
;
Aimin ZHANG
;
Jianquan CHEN
;
Guoxiang CHENG
Author Information
1. School of Life Science and Technology, Tongji University, Shanghai 200092, China.
- Publication Type:Journal Article
- MeSH:
Amino Acid Sequence;
Animals;
Base Sequence;
Cloning, Molecular;
Escherichia coli;
genetics;
metabolism;
Humans;
Immunoglobulin Heavy Chains;
biosynthesis;
genetics;
Immunoglobulin Variable Region;
biosynthesis;
genetics;
Mice;
Molecular Sequence Data;
Recombinant Proteins;
biosynthesis;
genetics;
Single-Chain Antibodies;
biosynthesis;
genetics;
Vascular Endothelial Growth Factor A;
genetics;
metabolism
- From:
Chinese Journal of Biotechnology
2010;26(11):1555-1562
- CountryChina
- Language:Chinese
-
Abstract:
In the application of therapeutic antibodies, large molecular weight of antibodies is always a problem that prevents them from penetrating into tissues or binding to antigenic determinants. To overcome this problem, we investigated the function of the heavy chain variable domain of a monoclonal anti-VEGF human IgM antibody derived from the Five-Feature Translocus Mice. We cloned the cDNA of the heavy chain variable domain, which was then inserted into pET28a vector and expressed in Escherichia coli. After purification and renaturation of the denatured recombinant protein, we obtained a 16 kDa antibody fragment, which is named as rhVVH. By immunoassaying its VEGF-binding capability in vitro, we proved that rhVVH retains this activity as the complete IgM. Importantly, rhVVH is shown to inhibit the HUVEC cell proliferation in a concentration-dependent manner. Our results indicate that the single heavy chain variable domain might inherit part of the biological function of the complete IgM antibody, which provided a valuable potential in further research on antibody miniaturisation.
